Last reviewed: June 23, 2026
Last updated: June 23, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Many people using semaglutide for weight loss also take creatine to support muscle preservation during rapid fat loss. However, the combination requires understanding how GLP-1 medications affect kidney function and electrolyte balance—factors that directly influence creatine safety.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
How Semaglutide Affects Kidney Function and Creatine Metabolism
Semaglutide slows gastric emptying and can reduce fluid intake, which may lower blood volume and kidney perfusion temporarily. Creatine, a compound filtered through the kidneys, produces creatinine as a metabolic byproduct. When kidney filtration changes, serum creatinine levels may shift, potentially giving a false impression of declining kidney function even when glomerular filtration rate (GFR) remains stable.
GLP-1 medications have not been shown to directly damage kidney tissue in clinical trials. However, dehydration—a common side effect during dose escalation—can concentrate creatinine in the blood and stress the kidneys' filtering capacity. Patients starting semaglutide injections should prioritize consistent water intake before considering creatine supplementation.
The Precision Peptide Genetic Test offered by PlexusDx evaluates how your body processes peptide-signaling compounds, including factors affecting fluid balance and kidney-protective GLP-1 responses. Understanding your genetic profile can help determine whether creatine supplementation fits your personalized protocol.
Safety Considerations When Combining GLP-1 Therapy With Creatine
Baseline kidney function testing is essential before adding creatine to any GLP-1 regimen. A simple serum creatinine and estimated GFR (eGFR) measurement provides a kidney health snapshot. If eGFR is below 60 mL/min/1.73m², creatine supplementation is generally not recommended, regardless of GLP-1 use.
Adequate hydration becomes non-negotiable when combining these compounds. Creatine draws water into muscle cells, while semaglutide may reduce thirst signals and fluid intake. Aiming for at least 2.5–3 liters of water daily helps maintain kidney perfusion and prevents creatinine concentration. Many patients on semaglutide benefit from setting hydration reminders, especially during the first month of treatment.
Monitor for warning signs including decreased urination, dark urine, persistent fatigue, or swelling in the extremities. These symptoms warrant immediate discussion with your healthcare provider and may indicate that creatine supplementation should be discontinued during your weight loss phase.
Optimizing Muscle Preservation While Using Semaglutide Injections
Rapid weight loss from semaglutide can lead to muscle loss if protein intake and resistance training are inadequate. Rather than relying solely on creatine for muscle support, prioritize consuming 0.7–1.0 gram of protein per pound of target body weight daily. Semaglutide's appetite-suppressing effect makes meal planning and nutrient-dense food selection critical for preserving lean mass.
Resistance training 3–4 times per week, combined with adequate protein and consistent hydration, has stronger evidence for muscle preservation than creatine supplementation alone. PlexusDx patients starting compounded semaglutide injections—whether the standard formulation or specialized microdose protocols—should discuss a structured exercise plan with their care team before introducing creatine.
If your healthcare provider confirms normal kidney function and optimal hydration practices are in place, creatine at standard doses (3–5 grams daily) poses minimal additional risk during semaglutide treatment. However, this decision should always be individualized based on your baseline kidney health and genetic predisposition to fluid retention or electrolyte shifts.
PlexusDx Semaglutide Therapy and Personalized Supplement Guidance
PlexusDx offers compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan through licensed 503A pharmacies, with no membership fees or insurance requirement. All patients receive guidance on foundational nutrition, hydration, and exercise—elements that directly influence whether additional supplements like creatine are safe or necessary.
The PlexusDx Precision Peptide Genetic Test ($298) analyzes MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
HSA and FSA accounts can be used to cover PlexusDx treatment costs and genetic testing across all 50 states. Before combining any supplement with your weight loss medication, discuss your specific protocol with your PlexusDx care team to ensure creatine aligns with your kidney health, hydration status, and genetic profile.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.
Frequently Asked Questions
Can I start creatine immediately after beginning semaglutide injections?
No. Wait at least 2–3 weeks into semaglutide treatment to allow your kidney function to stabilize and your hydration practices to become consistent. Confirm baseline kidney function with your provider before adding creatine, and ensure eGFR is above 60 mL/min/1.73m².
Does semaglutide damage the kidneys or increase creatinine levels?
Clinical trials have not shown direct kidney tissue damage from semaglutide. However, dehydration during treatment can temporarily elevate serum creatinine without indicating true kidney disease. This is why maintaining hydration and monitoring kidney function regularly is essential when using GLP-1 therapy.
How much does PlexusDx semaglutide cost and what's included?
Compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan with no flat per-compound pricing increases. PlexusDx serves all 50 states, requires no insurance, and prices remain flat across commitment tiers. The Precision Peptide Genetic Test is available for $298 to guide personalized supplementation decisions.
What side effects should make me stop taking creatine with semaglutide?
Discontinue creatine if you experience reduced urination, dark urine, fatigue, swelling, or sharp changes in weight loss rate. These may indicate dehydration or kidney stress. Always consult your provider before stopping any supplement, especially while adjusting to semaglutide.
How does the Precision Peptide Genetic Test help with creatine safety?
No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (MC4R (rs17782313)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What Percentage of People Lose Weight on Ozempic?
Ozempic® and Your A1C: Navigating Eligibility for a Healthier Future